DISCOUNT ZERTIFIKAT - BECTON DICKINSON AND CO. Stock

Certificat

DE000MG1B351

Market Closed - Börse Stuttgart 03:05:29 2024-05-31 pm EDT
186.7 EUR +0.62% Intraday chart for DISCOUNT ZERTIFIKAT - BECTON DICKINSON AND CO.
Current month-1.01%
1 month-1.01%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-31 186.7 +0.62%
24-05-30 185.5 -0.03%
24-05-29 185.6 +0.06%
24-05-28 185.5 +0.05%
24-05-27 185.4 -0.28%

Delayed Quote Börse Stuttgart

Last update May 31, 2024 at 03:05 pm EDT

More quotes

Static data

Product typeDiscount Certificates
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer Morgan Stanley
WKN MG1B35
ISINDE000MG1B351
Date issued 2024-04-02
Maturity 2025-03-21 (294 Days)
Parity 1 : 1
Emission price 190.8
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 189.7
Lowest since issue 184.4
Spread 0.08
Spread %0.04%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
232 USD
Average target price
278.7 USD
Spread / Average Target
+20.14%
Consensus